MARKET

CHFS

CHFS

CHF Solutions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7360
-0.1041
-12.39%
Closed 16:00 12/06 EST
OPEN
0.7998
PREV CLOSE
0.8401
HIGH
0.8358
LOW
0.7300
VOLUME
588.32K
TURNOVER
--
52 WEEK HIGH
13.90
52 WEEK LOW
0.6000
MARKET CAP
3.11M
P/E (TTM)
-0.0412
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CHFS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CHFS News

  • CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Memphis Methodist Le Bonheur Healthcare System
  • GlobeNewswire.3d ago
  • CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • GlobeNewswire.11/15 22:30
  • CHF Solutions Reports Offering Of ~767.6K Unit Offering Of Common Stock And Warrants
  • Benzinga.11/05 22:08
  • CHF Solutions EPS misses by $0.29, misses on revenue
  • seekingalpha.11/05 18:08

More

Industry

Advanced Medical Equipment & Technology
+0.69%
Healthcare Equipment & Supplies
+0.64%

Hot Stocks

Name
Price
%Change

About CHFS

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy. Aquadex is also indicated for extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overloads who have failed diuretic therapy and require hospitalization.
More

Webull offers CHF Solutions Inc (CHFS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.